SCHEMBL7091999

SCHEMBL7091999

CCN(CCCN(CCCCNC=O)S(=O)(=O)c1ccc(C)cc1)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
CNR2 P34972 2/20 0.46
HTT P42858 5/20 0.44
CA12 O43570 4/20 0.43
CA9 Q16790 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
LMNA P02545 3/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
CA1 P00915 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CA2 P00918 1/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
ABCC2 Q92887 1/20 0.43
SLC22A12 Q96S37 1/20 0.43
UGT1A7 Q9HAW7 1/20 0.43
SLC22A11 Q9NSA0 1/20 0.43
SERPINE1 P05121 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7206014 0.87 CNR2 (0.56) ALDH1A1CNR2HTTCA12CA9
SCHEMBL7201208 0.87 CNR2 (0.56) ALDH1A1CNR2HTTCA12CA9
SCHEMBL6895598 0.87 CNR2 (0.56) ALDH1A1CNR2HTTCA12CA9
SCHEMBL7095958 0.87 CNR2 (0.56) ALDH1A1CNR2HTTCA12CA9
SCHEMBL7092691 0.86 CNR2 (0.57) ALDH1A1CNR2HTTCA12CA9
SCHEMBL7206791 0.85 CA12 (0.59) ALDH1A1HTTCA12CA9LMNA
SCHEMBL7091255 0.84 CNR2 (0.59) ALDH1A1CNR2HTTCA12CA9
SCHEMBL7092601 0.84 CNR2 (0.59) ALDH1A1CNR2HTTCA12CA9
SCHEMBL7097469 0.84 CNR2 (0.59) ALDH1A1CNR2HTTCA12CA9
SCHEMBL7092599 0.84 CNR2 (0.59) ALDH1A1CNR2HTTCA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627399-B1 Using compound of given formula as accelerator RIKEN (JP) 2003-09-30 US disclosed
US-6605645-B2 Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action RIKEN (JP) 2003-08-12 US disclosed
US-20030073202-A1 RNA polymerase transcription promoter and nucleic acid sequencing method IWATA MASAAKI (JP) 2003-04-17 US disclosed
US-20020067472-A1 Linear polyamine compounds and polyamine anticancer agents IWATA MASAAKI (JP) 2002-06-06 US disclosed
US-6319956-B1 N1, N4-BIS(CYCLOPROPYLMETHYLAMINO)TRIALKYLENETETRAMINES THAT MAY BE TOLUENESULFONATED. RIKEN (JP) 2001-11-20 US disclosed
EP-1061130-A1 RNA POLYMERASE TRANSCRIPTION PROMOTERS AND METHOD FOR DETERMINING BASE SEQUENCE Riken (JP) 2000-12-20 EP disclosed